Latvia
Diabetes country report 2011 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Latvia (LV)
| 2011 | 166.3 thousand |
| 2024 | 126.6 thousand |
| 2050 | 102.4 thousand |
Latvia is one of the 60 countries and territories in the IDF Europe Region.
Data source(s) used for the diabetes estimates in adults:
- European Health Interview Study, 2008.
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | - | 166.3 | 126.6 | 102.4 |
| Age-standardised prevalence of diabetes, % | - | 7.8 | 7.1 | 8.1 |
| Proportion of people with undiagnosed diabetes, % | - | - | 28.5 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 36.1 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 60.9 | 47.0 |
| Age-standardised prevalence of IFG, % | - | - | 4.1 | 4.3 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 192.1 | 44.2 | 30.9 |
| Age-standardised prevalence of IGT, % | - | 9.9 | 2.5 | 2.5 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 1,817.0 | 735.2 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 5.3 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | 163.4 | 120.2 |
| Total diabetes-related health expenditure, ID million | - | - | 281.2 | 206.9 |
| Diabetes-related health expenditure per person, USD | - | 1,101.0 | 1,290.0 | 1,173.7 |
| Diabetes-related health expenditure per person, ID | - | - | 2,220.3 | 2,020.1 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 6,921.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 1,270.7 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | - | 1,709.9 | 1,316.9 | 1,027.2 |
| Population of children and adolescents (0-19 y) | - | - | 391,106.0 | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | - |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | - |
| Population of children and adolescents (0-19 y) | - |
